Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Developmental Biology

A subscription to JoVE is required to view this content.

CRISPR/Cas9-teknologi til genoprettelse af dystrophin-ekspression i iPSC-afledte muskel Progenitorer
 
Click here for the English version

CRISPR/Cas9-teknologi til genoprettelse af dystrophin-ekspression i iPSC-afledte muskel Progenitorer

Article DOI: 10.3791/59432-v 07:44 min September 14th, 2019
September 14th, 2019

Chapters

Summary

Please note that all translations are automatically generated.

Click here for the English version.

Her præsenterer vi en Cas9-baseret exon23 sletnings protokol for at genoprette dystrofin Expression i IPSC fra DMDMDX Mouse-afledte hudfibroblaster og direkte differentiere ipscs i myogenic stamceller (MPC) ved hjælp af tet-on myod aktiveringssystem.

Tags

Udviklingsbiologi inducerede pluripotente stamceller iPSC CRISPR/Cas9 DMD dystrofin myogen Progenitor differentiering
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter